1
|
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
|
Leukemia
|
2004
|
2.08
|
2
|
Clostridium difficile infection in patients with neutropenia.
|
Clin Infect Dis
|
2001
|
2.00
|
3
|
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients.
|
Support Care Cancer
|
2002
|
1.95
|
4
|
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
|
Leukemia
|
2005
|
1.72
|
5
|
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.
|
Br J Cancer
|
2003
|
1.57
|
6
|
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
|
Leukemia
|
2007
|
1.28
|
7
|
Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
|
Ann Hematol
|
2003
|
1.21
|
8
|
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
|
Eur J Clin Microbiol Infect Dis
|
2004
|
1.18
|
9
|
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis.
|
Leukemia
|
2012
|
1.07
|
10
|
Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment.
|
J Hosp Infect
|
2002
|
1.06
|
11
|
Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.
|
Haematologica
|
2001
|
1.02
|
12
|
Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
|
Anticancer Res
|
2005
|
1.01
|
13
|
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
|
Neurology
|
2005
|
0.99
|
14
|
Bisphosphonates in multiple myeloma.
|
Cochrane Database Syst Rev
|
2002
|
0.97
|
15
|
Early versus deferred treatment for early stage multiple myeloma.
|
Cochrane Database Syst Rev
|
2003
|
0.96
|
16
|
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
|
Ann Hematol
|
2003
|
0.95
|
17
|
Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors.
|
Chest
|
1998
|
0.94
|
18
|
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
|
Cancer Genet Cytogenet
|
2006
|
0.92
|
19
|
MR imaging of pneumonia in immunocompromised patients: comparison with helical CT.
|
AJR Am J Roentgenol
|
2000
|
0.91
|
20
|
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
|
Leukemia
|
2006
|
0.91
|
21
|
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.
|
Br J Cancer
|
2004
|
0.88
|
22
|
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML.
|
Ann Hematol
|
1999
|
0.87
|
23
|
False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
|
J Antimicrob Chemother
|
2008
|
0.86
|
24
|
Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature.
|
Mycoses
|
1998
|
0.86
|
25
|
Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia.
|
Infection
|
2002
|
0.81
|
26
|
Autoimmune neutropenia due to NA1 specific antibodies in primary biliary cirrhosis.
|
Br J Haematol
|
1991
|
0.81
|
27
|
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
|
Infection
|
2008
|
0.81
|
28
|
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer.
|
Cancer Treat Rev
|
2005
|
0.79
|
29
|
Severe abdominal infections in neutropenic patients.
|
Cancer Invest
|
2001
|
0.79
|
30
|
Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
|
Clin Cancer Res
|
2001
|
0.79
|
31
|
Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.
|
Support Care Cancer
|
2006
|
0.79
|
32
|
Protecting vulnerable groups in the home: the interface between institutions and the domestic setting.
|
J Infect
|
2001
|
0.79
|
33
|
[Diagnosis of systemic fungal infections in hematology. Standard recommendations of the Working Group for Infections in Hematology and Oncology of the German Association for Hematology and Oncology].
|
Dtsch Med Wochenschr
|
1999
|
0.78
|
34
|
In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
|
Br J Haematol
|
2006
|
0.78
|
35
|
Bisphosphonates in multiple myeloma.
|
Cochrane Database Syst Rev
|
2001
|
0.78
|
36
|
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
|
Support Care Cancer
|
2003
|
0.78
|
37
|
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
|
Leukemia
|
1996
|
0.77
|
38
|
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
|
Acta Haematol
|
2000
|
0.77
|
39
|
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
|
J Neurol Neurosurg Psychiatry
|
2001
|
0.77
|
40
|
Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
|
Leukemia
|
1996
|
0.77
|
41
|
Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.
|
Infection
|
2013
|
0.76
|
42
|
Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.
|
Anticancer Drugs
|
2003
|
0.76
|
43
|
Thalidomide in multiple myeloma.
|
Curr Pharm Biotechnol
|
2006
|
0.75
|
44
|
Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions.
|
J Hosp Infect
|
2003
|
0.75
|
45
|
[Pro and contra adjuvant chemotherapy in colorectal carcinoma].
|
Med Klin (Munich)
|
1996
|
0.75
|
46
|
[Primary non-Hodgkin lymphoma of the ovary].
|
Aktuelle Radiol
|
1998
|
0.75
|
47
|
[The typical radiological findings and course of invasive pulmonary aspergillosis in the immunosuppressed patient].
|
Rofo
|
1997
|
0.75
|
48
|
Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?
|
Ann Hematol
|
2001
|
0.75
|
49
|
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
|
Hematol Oncol
|
2000
|
0.75
|
50
|
[Aftercare in patients with colorectal carcinomas].
|
Dtsch Med Wochenschr
|
1995
|
0.75
|
51
|
Topoisomerase activities in undifferentiated acute myeloblastic leukemias and monocytic differentiated leukemias.
|
Recent Results Cancer Res
|
1997
|
0.75
|
52
|
[MRT versus CT in the diagnosis of pneumonias: an evaluation of a T2-weighted ultrafast turbo-spin-echo sequence (UTSE)].
|
Rofo
|
1999
|
0.75
|
53
|
Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient.
|
Nephrol Dial Transplant
|
1997
|
0.75
|
54
|
Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum.
|
Bone Marrow Transplant
|
2005
|
0.75
|
55
|
[Libyan patient with chronic diarrhea].
|
Z Gastroenterol
|
1996
|
0.75
|
56
|
Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia.
|
Curr Med Res Opin
|
2014
|
0.75
|
57
|
[Pharmacokinetics of colloidal bismuth subcitrate. Solution versus tablet].
|
Arzneimittelforschung
|
1993
|
0.75
|